Endocrine toxicity in cancer patients treated with nivolumab or pembrolizumab: results of a large multicentre study.
E M PresottoG RastrelliI DesideriV ScottiS GunnellaN PimpinelliE VaccherA BearzF Di CostanzoM BruggiaE MiniM MaggiAlessandro PeriPublished in: Journal of endocrinological investigation (2019)
Thyroid alterations are frequently associated with anti PD-1 treatment in cancer patients. Regular thyroid assessment should be performed, particularly in the first months of treatment and in patients with a pre-existing thyroid disease.